Rituxan Genentech(Health/Medications) non-hodgkins-lymphoma.rituxan.com Description: Information about NonHodgkins Lymphoma and Rituxan (Rituximab), the first U.S. approved... monoclonal antibody cancer treatment to treat NonHodgkins Lymphoma. Rituxan (Rituximab) is the first monoclonal antibody cancer therapy approved in the United States. Healthcare professionals can find clinical trial, dosage and administration, and patient reimbursement information (SPOC). Presented by Genentech, Inc, and Idec Pharmaceuticals, Inc Specializes in: nonhodgkinslymphomacancertreatmentnonhodgkinsbcellrituxan...rituximabmonoclonal